Bisphosphonate therapy in multiple myeloma: past, present, future.

Bisphosphonate therapy in multiple myeloma: past, present, future.

Item
http://www.wikidata.org/entity/Q35013342
Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options.Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism.Zoledronic acid suppresses metastasis of esophageal squamous cell carcinoma cells through upregulating the tight junction protein occludin.Zoledronic acid augments the radiosensitivity of cancer cells through perturbing S- and M-phase cyclins and p21CIP1 expression.Evolving therapeutic role of bisphosphonates in multiple myeloma.The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
P2860

Bisphosphonate therapy in multiple myeloma: past, present, future.

Item
http://www.wikidata.org/entity/Q35013342
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Bisphosphonate therapy in multiple myeloma: past, present, future.
@ast
Bisphosphonate therapy in multiple myeloma: past, present, future.
@en
type
label
Bisphosphonate therapy in multiple myeloma: past, present, future.
@ast
Bisphosphonate therapy in multiple myeloma: past, present, future.
@en
prefLabel
Bisphosphonate therapy in multiple myeloma: past, present, future.
@ast
Bisphosphonate therapy in multiple myeloma: past, present, future.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Bisphosphonate therapy in multiple myeloma: past, present, future.
@en
P2093
P2860
P304
P31
P356
10.1034/J.1600-0609.2002.02796.X
P433
P478
P577
P5875
P698